IL13 and Alzheimer disease: Although loss-of-function mutation of the FLG gene is the genetic abnormality most frequently associated with AD [95], an IL-4- and IL-13-deviated milieu is probably far more important in the pathogenesis of AD when we take into account the excellent efficacy of the anti-IL-4 receptor α antibody dupilumab for AD.